New-generation atrial antitachycardia pacing (Reactive ATP) is associated with reduced risk of persistent or permanent atrial fibrillation in patients with bradycardia: Results from the MINERVA randomized multicenter international trial

Luigi Padeletti, Helmut Pürerfellner, Lluis Mont, Raymond Tukkie, Antonis S. Manolis, Renato Ricci, Giuseppe Inama, Paolo Serra, Mike G. Scheffer, Vitor Martins, Eduardo N. Warman, Marco Vimercati, Andrea Grammatico, Giuseppe Boriani

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'New-generation atrial antitachycardia pacing (Reactive ATP) is associated with reduced risk of persistent or permanent atrial fibrillation in patients with bradycardia: Results from the MINERVA randomized multicenter international trial'. Together they form a unique fingerprint.

Medicine & Life Sciences